Modeling the correlation of linifanib (ABT-869) pharmacokinetic (PK) exposure and DCE-MRI response in patients with advanced or metastatic solid tumors

被引：0
|
作者：
Li, Xiaohui [1 ]
Jahn, Patrick [1 ]
Ashton, Edward [2 ]
Noertersheuser, Peter A. [1 ]
Carlson, Dawn M. [1 ]
Pradhan, Rajendra S. [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] VirtualScopics Inc, Rochester, NY USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-1277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1277
引用
收藏
页数：1
相关论文
共 27 条
  • [1] EFFECT OF KETOCONAZOLE ON THE PHARMACOKINETICS (PK) AND SAFETY PROFILE OF LINIFANIB (ABT-869) IN PATIENTS WITH ADVANCED SOLID TUMORS
    Lewis, L. D.
    Li, X.
    Pradhan, R.
    McKee, M.
    LoRusso, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S75 - S76
  • [2] ABT-869 response monitoring with DCE-MRI, PET and CT imaging in advanced solid tumor cancer patients
    Steinberg, Joyce
    Ricker, Justin
    Wong, Yu-Ning
    Tan, Eng-Huat
    Toh, Han Chong
    Kollmannsberger, Christian
    Qian, Jane
    Ashton, Edward
    Carlson, Dawn
    CANCER RESEARCH, 2009, 69
  • [3] Antiangiogenic effects of linifanib (ABT-869) in xenograft models and patients with solid tumors
    Jiang, F.
    Luo, Y. P.
    Tapang, P.
    Goh, B. C.
    Wong, C. I.
    Soo, R.
    Albert, D.
    McKee, M.
    Ricker, J. L.
    McKeegan, E.
    EJC SUPPLEMENTS, 2010, 8 (07): : 188 - 188
  • [4] Population pharmacokinetic (PK) analysis of ABT-869 in solid tumors and acute myelogenous leukemia (AML) patients
    Gupta, N.
    Diderichsen, P. M.
    Steinberg, J.
    Ricker, J. L.
    Humerickhouse, R.
    Awni, W.
    Pradhan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] PLACENTAL GROWTH FACTOR (PIGF) AS A BIOMARKER IN PATIENTS (PTS) WITH SOLID TUMORS TREATED WITH LINIFANIB (ABT-869)
    Mc Keegan, E. M.
    Goh, B. C.
    Toh, H. C.
    Tannir, N.
    Chakravartty, A.
    Ansell, J.
    Datwyler, S.
    McKee, M. D.
    Ricker, J. L.
    Carlson, D. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [6] Phase 2 trials of linifanib (ABT-869) in advanced hepatocellular, renal cell and non-small cell lung cancer: Associations of response by CT or DCE-MRI with patient outcome
    Toh, Han Chong
    Yong, Wei Peng
    Wang, Yu-Ning
    Tan, Eng-Huat
    Kollmannsberger, Christian K.
    Devanarayan, Viswanath
    Zhang, Ke
    Luo, Yanping
    Chen, Daniel
    Ashton, Edward
    Ricker, Justin L.
    Carlson, Dawn
    Chen, Pei-Jer
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors
    Asahina, Hajime
    Tamura, Yosuke
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Seki, Yoshitaka
    Shibata, Takashi
    Goto, Yasushi
    Tanioka, Maki
    Yamada, Yasuhide
    Coates, Andrew
    Chiu, Yi-Lin
    Li, Xiaohui
    Pradhan, Rajendra
    Ansell, Peter J.
    McKeegan, Evelyn M.
    McKee, Mark D.
    Carlson, Dawn M.
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1477 - 1486
  • [8] An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors
    Hajime Asahina
    Yosuke Tamura
    Hiroshi Nokihara
    Noboru Yamamoto
    Yoshitaka Seki
    Takashi Shibata
    Yasushi Goto
    Maki Tanioka
    Yasuhide Yamada
    Andrew Coates
    Yi-Lin Chiu
    Xiaohui Li
    Rajendra Pradhan
    Peter J. Ansell
    Evelyn M. McKeegan
    Mark D. McKee
    Dawn M. Carlson
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1477 - 1486
  • [9] Assessment of pharmacokinetic (PK) interactions between Carboplatin (C), Paclitaxel (P) and ABT-869 in patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Gupta, Neeraj
    Palaparthy, Rameshraja
    Awni, Walid
    Carlson, Dawn
    Pradhan, Rajendra
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S669 - S669
  • [10] POPULATION PHARMACOKINETIC MODELING OF NGM438 IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS
    Yan, L.
    Xie, S.
    Boesmans, S.
    Rivera, L.
    Li, W.
    Goodyear, A.
    Zheng, L.
    Abhyankar, D.
    Hanes, V.
    Sloan-Lancaster, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S97 - S97
123